世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
58期
8-8,10
,共2页
心房颤动%华法林%阿司匹林%抗凝
心房顫動%華法林%阿司匹林%抗凝
심방전동%화법림%아사필림%항응
Atrial fibrillation%Hua Falin%aspirin%anticoagulation
目的：通过研究对我地区华法林应用的现状及原因进行分析，同时比较阿司匹林与华法林在心房纤颤中预防血栓栓塞事件的有效性及安全性。方法根据入选标准，房颤患者随机分为阿司匹林组（对照组）与华法林组，华法林组部分为住院患者调节剂量后门诊随访，部分为全程门诊随访，记录两组患者的血栓栓塞事件及出血事件。结果共160例患者进入分析，华法林组80例，阿司匹林组80例，随访2年。结论华法林组可明显降低房颤患者的血栓栓塞事件，但出血的发生率稍高于阿司匹林组，但大部分出血为非致死性，可以及时控制。整体评价华法林在房颤中的抗凝治疗利明显大于弊，值得临床上全面推广，尤其在基层医院，临床医生的指导及经验起到关键作用。
目的：通過研究對我地區華法林應用的現狀及原因進行分析，同時比較阿司匹林與華法林在心房纖顫中預防血栓栓塞事件的有效性及安全性。方法根據入選標準，房顫患者隨機分為阿司匹林組（對照組）與華法林組，華法林組部分為住院患者調節劑量後門診隨訪，部分為全程門診隨訪，記錄兩組患者的血栓栓塞事件及齣血事件。結果共160例患者進入分析，華法林組80例，阿司匹林組80例，隨訪2年。結論華法林組可明顯降低房顫患者的血栓栓塞事件，但齣血的髮生率稍高于阿司匹林組，但大部分齣血為非緻死性，可以及時控製。整體評價華法林在房顫中的抗凝治療利明顯大于弊，值得臨床上全麵推廣，尤其在基層醫院，臨床醫生的指導及經驗起到關鍵作用。
목적：통과연구대아지구화법림응용적현상급원인진행분석，동시비교아사필림여화법림재심방섬전중예방혈전전새사건적유효성급안전성。방법근거입선표준，방전환자수궤분위아사필림조（대조조）여화법림조，화법림조부분위주원환자조절제량후문진수방，부분위전정문진수방，기록량조환자적혈전전새사건급출혈사건。결과공160례환자진입분석，화법림조80례，아사필림조80례，수방2년。결론화법림조가명현강저방전환자적혈전전새사건，단출혈적발생솔초고우아사필림조，단대부분출혈위비치사성，가이급시공제。정체평개화법림재방전중적항응치료리명현대우폐，치득림상상전면추엄，우기재기층의원，림상의생적지도급경험기도관건작용。
Objective: Through the study, the present situation of the application region of warfarin to me and the reason is analyzed, at the same time comparing aspirin and warfarin in prevention of thromboembolic events in atrial fibrillation is effective and safety. Method: According to the inclusion criteria, atrial fibrillation patients were randomly divided into the aspirin group (control group) with warfarin group and warfarin group for hospitalized patients adjust the dose of outpatient follow-up after part for outpatient follow-up, all the records in the two groups in patients with thromboembolism and bleeding events.Results: A total of 160 patients entered the analysis of warfarin group 80 cases, 80 cases of aspirin group were followed up for 2 years.Conclusion: Warfarin group can obviously reduce thromboembolic nts in patients with atrial fibrillation, but the incidence of bleeding is higher than the aspirin group, but the majority of bleeding for nonfatal, can control in a timely manner. The overall evaluation of warfarin anticoagulant therapy in clearly outweigh the disadvantages, and worthy of clinical comprehensive promotion, especially in the basic-level hospitals,clinical doctor’s guidance and experience play a key role.
